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Obstructive jaundice damages critical functions in the liver. Nitric oxide modulation would inﬂuence liver damage induced by
biliary obstruction, and little is known about it Acute cholestasis was induced by bile duct ligation (BDL) in two groups of
male Sprague-Dawley rats. L-Arginine or serum physiologic was administered to treatment and control group. Histopathological
and immunohistochemical iNOS expression was investigated in hepatic tissue. Plasma enzyme activities were increased in acute
cholestasis, and that L-arginine treatment partially but signiﬁcantly prevented the elevation of these markers of liver damage
(P< .05). Also histopathology scoring showed that the liver injury was prevented and immunohistochemical iNOS activity was
increased signiﬁcantlyin L-arginine group (P<.05). This study showsthat, after 7 days of biliary obstruction, liver damage is well
established and exogenous L-arginine treatment partially but signiﬁcantlyprevented the liver injury in acute cholestasis.
1.Introduction
Biliary obstruction is a common surgical problem. Despite
the advances in diagnostic and therapeutic modalities, its
morbidity and mortality are high. Cardiovascular dysfunc-
tion, peripheral vasoconstriction, renal insuﬃciency, gas-
trointestinal hemorrhage, coagulopathy,and sepsis aremajor
complications that aﬀect its morbidity and mortality [1].
According to experimental and clinical studies, these com-
plicationsdevelopbecause of hypotension, immunosuppres-
sion, hepatic dysfunction, and high serum levels of toxic
substances such as bile salts and endotoxin [1]. Nitric oxide
(NO), which appears as an intercellular and intracellular
messenger, has a role in liver damage. The synthesis of NO
from L-arginine is known to exist in a number of cells,
includingendothelialcells, macrophages, cerebellar neurons,
neutrophils, Kupﬀer cells, and hepatocytes [2]. Macrophages
and hepatocytes produce much greater quantities of NO,
which is not detectable until several hours after exposure to
a speciﬁc inﬂammatory or septic stimulus [3]. Although the
roles of NO in liver damage induced by ischemia reperfusion
[4], alcohol [5], dimethylnitrosamine [6], and immunologi-
cal [7] liver injury have been studied, the function of NO in
liver damage induced by bile duct ligation in the rat has not
been ascertained.
This study was undertaken to determine if an alteration
in NO production caused by external L-arginine administra-
tion would inﬂuence the degree of hepatic damage induced
by a seven-day biliary obstruction.
2.Materialand Methods
2.1. Animals. Thirty male Sprague-Dawley rats weighting
200–250g were housed under standard laboratory condi-
tions and allowed free access to food and water. Institutional2 HPB Surgery
Table 1: Comparison of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and γ-glutamyl transpeptidase levels
in sham-operated, obstructive jaundice and L-arginine groups.
Group T. bilirubin D. bilirubin AST ALT ALP GGT
U/L U/L U/L U/L U/L U/L
Sham (saline) 0.27 ± 0.30 .02 ±0.01 131 ±23 90 ±36 224 ± 42 2 ± 2
O b s t r u c t i v ej a u n d i c e( s a l i n e ) 1 0±3.08 .00 ±2.00 763 ±88a 233 ±74a 533 ± 11a 25 ± 11a
L-Arginine 7 ±2.06 .00 ±2.00 347 ±22
b 141 ±71
b 365 ± 9b 15 ± 4b
Data are shown as means ± S.E.M.; ten rats were used in each group.
aP <. 05 Mann-Whitney U- t e s ti nc o m p a r i s o nw i t hs h a m( s a l i n e )g r o u p .
bP <. 05 Mann-Whitney U- t e s ti nc o m p a r i s o nw i t ho b s t r u c t i v ej a u n d i c e( s a l i n e )g r o u p .
guidelines for animal care were followed throughout the
experimental study. The rats were anesthetized by intramus-
cular 50mg/kg ketamine hydrochloride (Ketalar, Eczacıbas ¸ı,
Turkey) and 5mg/kg xylazine hydrochloride (Rompun %2,
Bayer). Extra hepatic cholestasis was induced by double
ligation and section of the common bile duct with a 4/0
silk suture. Three groups of rats (n = 10) were used. The
animals of the ﬁrst group were sham operated. In the second
group, animals were bile duct ligatured (BDL) and received
1mL % 0.9 NaCltwice a day intraperitoneally (i.p.).Animals
in the third group were BDL and given i.p. administration
of 1mL 500mg/kg L-arginine twice a day. All the animals
were sacriﬁced on the seventh day under ether anesthesia.
Blood was collected by cardiac puncture, and the liver was
rapidly removed. Small liver sections from the same lobe of
liverfrom each rat were ﬁxed in 10%neutral formalin, which
was used for hematoxylin-eosin staining for histological and
immunohistochemical examination under light microscopy.
2.2. Serum Enzyme Activities and Bilirubin Determination.
Serum was also obtained for determination of aspartate
aminotransferase (AST), alanine aminotransferase (ALT)
[8], alkaline phosphatase (ALP) [9], and γ-glutamyl tran-
speptidase (γGTP) [10, 11] activities. All of these markers,
especially ALT, ALP, and γGTP, are indicators of liver dam-
age. Bilirubin content (kit from Mega, Merk, Germany) was
studied for signs of cholestasis.
2.3. Histopathology and Immunocytochemistry. Liver histo-
pathology was evaluated to show the eﬀect of NO on cho-
lestatic liver injury. Immunohistochemical study was per-
formed to explain the eﬀect of exogenous L-arginine on
hepatic inducible nitric oxide syntheses (iNOS) expression.
Histopathological studies were performed on 5-μms l i d e s .
Inducible nitric oxide synthase (iNOS) was determined im-
munohistochemically by a standardized streptavidin-biotin-
peroxidase method on formaline-ﬁxed paraﬃn-embedded
liver tissue. A quantitative method was used for immuno-
histochemical evaluation; the staining score was obtained by
calculating the number of iNOS-stained epithelial cells per
100 asinus under 40x light microscopy.
Histopathological evaluation was performed with a
quantitative method. Ten diﬀerent squares were used in each
section to score the injury in the liver tissue. We used a mod-
iﬁed scoring system for focal hepatic necrosis, as described
by Orrego et al. [1], which takes into account necrosis, bile
duct proliferation, and periportal leukocyte inﬁltration [12]
(Tables 2 and 3), under 40x light microscopy (Olympus
Bx40, Japan).
3.Results
All bilirubins increased progressively after bile duct obstruc-
tion and reached a plateau between three and seven days
after surgery. Because of the cholestatic liver damage, plasma
bilirubin levels and the activities of aspartate aminotrans-
ferase [8], alanine aminotransferase, alkaline phosphatase
[9]a n dγ-glutamyl transpeptidase [10, 11]w e r ea l ls i g n i ﬁ -
cantly higher in BDL rats than in sham-operated rats (P<
.001, Table 1).
L-arginine administration partially but signiﬁcantly pre-
vented the elevation ofplasma enzyme activities in bileduct-
ligated rats (P<. 05, Table 1).
Histopathological studies showed signiﬁcant diﬀerences
between obstructive jaundice and L-arginine groups in
hematoxylin-eosin-(H-E)-stained sections. In the obstruc-
tive jaundice group, swelling and vacuolization in the cyto-
plasm of hepatocytes, loss of eosinophilic structures, and
nucleolusproliferationwereseen.Dilatationofsinusoidsdue
toperiportal,perisinusoidal,andpolimorpho-andmononu-
clear leukocyte inﬁltration was noticeable. Focal hepatic
necrosis and periportal new bile canaliculi proliferation were
also observed (Figure 1). These ﬁndings were less evident in
the L-arginine treatment group in which there was minimal
periportal, perisinusoidal, polimorpho- and mononuclear
leukocyte inﬁltration. There were also less piknotic nucleus
cells and necrosis in the exogen L-arginine-administered
group (Figure 2)a n d( T a b l e s2 and 3).
Immunohistochemical staining was evaluatedinthehep-
atocytes using cytoplasmic patterns. In the sham-operated
group, iNOS staining was almost absent in liver parenchyma
and periportal areas (Figure 3). In the bile duct-ligated
group, iNOS staining was most evidentin necroticareas, and
observed to a lesser extent in liver parenchyma (Figure 4).
Inthesameareasintheobstructivejaundice+L-arginine
group, iNOS staining intensity increased with L-arginine
administration, and focal necrosis, bile duct proliferation,
and periportal leukocyte inﬁltration were partially, but
signiﬁcantly, (P<. 001) prevented (Figure 5).
The iNOS tissue staining scores were 15.85% in the sham-
operated group, 32.70% in the BDL group, and 65.22% in
the obstructive jaundice + L-arginine group; there were sig-HPB Surgery 3
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Figure 1: The liver histopathological changes in obstructive jaun-
dice group, H-E ×40 Focal necrose areas (a), bile duct proliferation
(b)andperiportal PMNleucocytes inﬁltration(c).CV:central vein.
P: portal vein.
Table 2: Cholestatic liver injury scale.
Necrosis
No necrosis (0 point)
Necrosis in one and/or two cells (1 point)
Focal necrosis that involves more than two cells (2 point)
Massive conﬂuent necrosis (3 point)
Zonal massive necrosis and bridging necrosis between
central veins (4 point)
Bile duct proliferation
1-2 bile canaliculi proliferation (1 point)
3-4 bile canaliculi proliferation (2 point)
>4 bile canaliculi proliferation (3 point)
Periportal leukocyte inﬁltration
Mild inﬁltration with one or two cells (1 point)
Moderate inﬁltration with more than two cells (2 point)
Diﬀuse inﬁltration (3 point)
Table 3: Cholestatic liver injury score.
Obstructive
jaundice group
L-arginine
group
Focal necrotic areas 2.11 0.22
a
Ductus proliferation 2.7 1.44
a
Periportal leukocyte inﬁltration 2.4 1.22a
Total score 7.2 2.8
a
aP <. 001, Mann-Whitney U-test, in comparison with cholestatic (saline)
group.
niﬁcant diﬀerences between the obstructive jaundice and L-
arginine groups.
4.Discussion
In this work, we have studied the eﬀects of exogenous L-
arginine on the production of NO by regulating the expres-
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Figure 2: The liver histopathological changes in L-arginine group,
H-E ×40. Less bile duct proliferation (b) and periportal PMN
leukocyteinﬁltration(c)withnonecrosis.CV :centralvein.P:P ortal
vein.
Figure 3: Sham group was not dyed by iNOS. (iNOS ×40).
sion of iNOS proteins. We have also studied the eﬀect of
exogenous arginine on cholestatic liver injury. Recent obser-
vations provide evidence that NO plays an important role
in liver disease, but little is known about the role of
arginine-iNOS pathways in cholestatic liver injury [3, 13].
Bile duct ligation in the rat is a good model to study
drugs that might prevent or reverse liver injury [3]. In this
study’s experiments, we have shown that, after seven days of
biliary obstruction, liver damage was well established and is
accompanied by decreased production of iNOS protein and
elevated liver enzymes. As a consequence of the decrease in
iNOS synthesis, liver blood supply and perfusion decreased.
Ischemia and necrosis were observed in the liver under light
microscopy [14].
Recent researches about the role of NO in the regu-
lation of hepatic microcirculation have shown that the L-
arginine-derived iNOS activation supports vasodilatation
and inhibition of platelet functions. NO may exhibit its
protective eﬀects against liver injury through vasodilatation
and inhibition of platelet and macrophage activities [15,
16]. In addition, studies in cholestatic rats have shown an
association with hepatic ischemia because of the deﬁcient
production of iNOS and protein. This supports the hypoth-
esis that NO regulates blood ﬂow in cholestatic rats [17, 18].4 HPB Surgery
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Figure 4: The liver iNOS staining in obstructive jaundice group,
H-E ×40. A few areas iNOS staining (i), bile duct proliferation
(b), and periportal PMN leucocytes inﬁltration (c). CV: central
vein, P: portal vein (in the bile duct-ligated group, iNOS staining
was observed most evidently in necrotic areas and also less in liver
parenchyma).
Figure 5: The liver iNOS staining increased in L-arginine group,
H-E ×40. Diﬀuse iNOS staining in L-arginine group.
However, diﬀerentresultswere shown forthe production
of NO in acute cholestasis. While several studies have
suggested that there is overproduction of NO in their
experimental models of bile duct ligation [19], the results
of other studies about cholestasis do not support this hy-
pothesis [13] because they do observe the inhibition of NO
production in cholestasis. Also, endogen iNOS activity was
not increased, even in portal-hypertensive and cirrhotic rats
[20, 21]. The same is true for BDL rats, as we have shown
immunohistochemically in the current study [13].
In the current study, after exogenous L-arginine admin-
istration to cholestatic rats, iNOS expression and nitric oxide
productionweresigniﬁcantlyincreasedandshown immuno-
histochemically for the ﬁrst time. There is no previous study
that has investigated the eﬀects of exogenous L-arginine
on liver iNOS expression and histopathological changes in
acutecholestasis. ExogenousL-arginine isimportant because
several studies have shown that L-arginine utilization is
increased during obstructive cholestasis or endotoxemia
[22, 23], and exogenous L-arginine administration partially
but signiﬁcantly prevented the elevation of liver enzymes.
However, there are no studies about the histopathological
ﬁndings of exogenous L-arginine on cholestatic liver injury.
Our study showed that histopathological changes, such as
focal necrosis, new bile canaliculi proliferation, and peri-
portal leukocyte inﬁltration, were partially but signiﬁcantly
prevented by exogenous L-arginine in obstructive jaundiced
rats. L-arginine played a protective role by inducing iNOS
expression and NO synthesis, and this is also shown histo-
pathologicallyandimmunohistochemically fortheﬁrst time.
Muriel and Gonz´ alez [3]a n d[ 23]h a v es h o w nt h ee ﬀects
of exogenous L-arginine in BDL rats with liver enzymes
with markers of liver damage. Muriel suggested that L-
arginine-induced NO production plays a protective role in
cholestatic liver injury induced by 3-day biliary obstruction
and showed this through decreased liver enzyme levels
and lipid peroxidation, but further studies are needed to
s h o wt h ep r o t e c t i v ee ﬀects of exogenous L-arginine with
histopathologicalﬁndingsandspeciﬁcmarkersofliverinjury
[23]. The current experimental study has demonstrated that
exogenousL-arginine partially butsigniﬁcantly decreases the
liver enzyme levels and histopathological liver injury.
In summary, the present study suggests that L-arginine
treatment partially but signiﬁcantly prevents the liver injury
in acute cholestasis by stimulation of iNOS expression and
NOsynthesis. Thisisshown histopathologicallyandimmun-
ohistochemically for the ﬁrst time.
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